Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Comments on the 2016 ESC Guidelines for the Management of Atrial Fibrillation.

Arribas F; SEC Working Group for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:., Arribas F, Roldán I, Luis Merino J, Roldán V, Arenal Ÿ, Tamargo J, Ruiz-Granell R, Mont L, Anguita M, Marín F; Reviewers for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:., Barrios Alonso V, Barón G, Esquivias, Cosín Sales J, Díaz Infante E, Escobar Cervantes C, Ferreiro Gutiérrez JL, Guerra Ramos JM, Jiménez Candil FJ, Pérez Castellano N, Sambola Ayala A, Tello Montoliu A; SEC Guidelines Committee:., San Román A, Alfonso F, Arribas F, Evangelista A, Ferreira I, Jiménez M, Marín F, de Isla LP, Rodríguez Padial L, Sánchez PL, Sionis A, Vázquez R.

Rev Esp Cardiol (Engl Ed). 2017 Jan;70(1):2-8. doi: 10.1016/j.rec.2016.11.032. English, Spanish. No abstract available.

PMID:
28038728
2.

Characterization of left and right atrial function in healthy volunteers by cardiovascular magnetic resonance.

Maceira AM, Cosin-Sales J, Prasad SK, Pennell DJ.

J Cardiovasc Magn Reson. 2016 Oct 10;18(1):64.

3.

Usefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Patients in Spain: A Cost-effectiveness Study.

Barrios V, Kaskens L, Castellano JM, Cosin-Sales J, Ruiz JE, Zsolt I, Fuster V, Gracia A.

Rev Esp Cardiol (Engl Ed). 2017 Jan;70(1):42-49. doi: 10.1016/j.rec.2016.05.009. English, Spanish.

PMID:
27474481
4.

Real-world Data on the Efficacy of Vernakalant for Pharmacological Cardioversion in Patients With Recent-onset Atrial Fibrillation.

Cosin-Sales J, Loscos A, Peiró A, Sorando MR, Buendía F, Ruescas L.

Rev Esp Cardiol (Engl Ed). 2016 Jun;69(6):619-20. doi: 10.1016/j.rec.2016.02.020. English, Spanish. No abstract available.

PMID:
27131972
5.

[Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain].

Cosin Sales J, Fuentes Jiménez FJ, Mantilla Morató T, Ruiz E, Becerra V, Aceituno S, Ferrario MG, Lizán L, Gracia A.

Clin Investig Arterioscler. 2015 Sep-Oct;27(5):228-38. doi: 10.1016/j.arteri.2014.11.003. Spanish.

PMID:
25640158
6.

Long term effects of cocaine on the heart assessed by cardiovascular magnetic resonance at 3T.

Maceira AM, Ripoll C, Cosin-Sales J, Igual B, Gavilan M, Salazar J, Belloch V, Pennell DJ.

J Cardiovasc Magn Reson. 2014 Apr 23;16:26. doi: 10.1186/1532-429X-16-26.

7.

Reference right atrial dimensions and volume estimation by steady state free precession cardiovascular magnetic resonance.

Maceira AM, Cosín-Sales J, Roughton M, Prasad SK, Pennell DJ.

J Cardiovasc Magn Reson. 2013 Apr 8;15:29. doi: 10.1186/1532-429X-15-29.

8.

Effects of hawthorn (Crataegus laevigata) on platelet aggregation in healthy volunteers.

Dalli E, Vallés J, Cosín-Sales J, Santos MT, Moscardó A, Milara J, Sotillo JF.

Thromb Res. 2011 Oct;128(4):398-400. doi: 10.1016/j.thromres.2011.06.006. No abstract available.

PMID:
21737127
9.

Anticoagulation prescription in atrial fibrillation.

Bertomeu-González V, Cordero A, Mazón P, Moreno-Arribas J, Fácila L, Nuñez J, Rodríguez-Mañero M, Cosín-Sales J, González-Juanatey JR, Quiles J, Bertomeu-Martínez V; investigators of the CARDIOTENS2 study..

Expert Opin Pharmacother. 2011 Jul;12(10):1473-9. doi: 10.1517/14656566.2011.584063.

PMID:
21635195
10.

Crataegus laevigata decreases neutrophil elastase and has hypolipidemic effect: a randomized, double-blind, placebo-controlled trial.

Dalli E, Colomer E, Tormos MC, Cosín-Sales J, Milara J, Esteban E, Sáez G.

Phytomedicine. 2011 Jun 15;18(8-9):769-75. doi: 10.1016/j.phymed.2010.11.011.

PMID:
21242072
11.

Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance.

Maceira AM, Cosín-Sales J, Roughton M, Prasad SK, Pennell DJ.

J Cardiovasc Magn Reson. 2010 Nov 11;12:65. doi: 10.1186/1532-429X-12-65.

12.

Hawthorn extract inhibits human isolated neutrophil functions.

Dalli E, Milara J, Cortijo J, Morcillo EJ, Cosín-Sales J, Sotillo JF.

Pharmacol Res. 2008 Jun;57(6):445-50. doi: 10.1016/j.phrs.2008.05.001.

PMID:
18547815
13.

Prognostic value of circulating pregnancy-associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (pro-MBP) levels in patients with chronic stable angina pectoris.

Consuegra-Sanchez L, Petrovic I, Cosin-Sales J, Holt DW, Christiansen M, Kaski JC.

Clin Chim Acta. 2008 May;391(1-2):18-23. doi: 10.1016/j.cca.2008.01.012.

PMID:
18267116
14.

Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris.

Cosin-Sales J, Kaski JC, Christiansen M, Kaminski P, Oxvig C, Overgaard MT, Cole D, Holt DW.

Eur Heart J. 2005 Oct;26(20):2093-8.

15.

Silent myocardial ischaemia: clinical relevance and treatment.

Kaski JC, Cosín Sales J, Arroyo Espliguero R.

Expert Opin Investig Drugs. 2005 Apr;14(4):423-34. Review.

PMID:
15882118
16.

Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes.

Avanzas P, Arroyo-Espliguero R, Cosín-Sales J, Aldama G, Pizzi C, Quiles J, Kaski JC.

Heart. 2004 Aug;90(8):847-52.

17.

Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina.

Avanzas P, Arroyo-Espliguero R, Cosín-Sales J, Quiles J, Zouridakis E, Kaski JC.

Atherosclerosis. 2004 Jul;175(1):151-7.

PMID:
15186960
18.

Cardiac syndrome X. Diagnosis, pathogenesis and management.

Kaski JC, Aldama G, Cosín-Sales J.

Am J Cardiovasc Drugs. 2004;4(3):179-94. Review.

PMID:
15134470
19.

C-reactive protein elevation and disease activity in patients with coronary artery disease.

Arroyo-Espliguero R, Avanzas P, Cosín-Sales J, Aldama G, Pizzi C, Kaski JC.

Eur Heart J. 2004 Mar;25(5):401-8.

20.
Items per page

Supplemental Content

Loading ...
Support Center